Literature DB >> 16399078

Polycystin-1, STAT6, and P100 function in a pathway that transduces ciliary mechanosensation and is activated in polycystic kidney disease.

Seng Hui Low1, Shivakumar Vasanth, Claire H Larson, Sambuddho Mukherjee, Nikunj Sharma, Michael T Kinter, Michelle E Kane, Tomoko Obara, Thomas Weimbs.   

Abstract

Primary cilia are implicated in the pathogenesis of autosomal-dominant polycystic kidney disease (ADPKD), which results from defects in polycystin-1 (PC1), but the function of PC1 remains poorly understood. Here, we show that PC1 undergoes proteolytic cleavage that results in nuclear translocation of its cytoplasmic tail. The PC1 tail interacts with the transcription factor STAT6 and the coactivator P100, and it stimulates STAT6-dependent gene expression. Under normal conditions, STAT6 localizes to primary cilia of renal epithelial cells. Cessation of apical fluid flow results in nuclear translocation of STAT6. Cyst-lining cells in ADPKD exhibit elevated levels of nuclear STAT6, P100, and the PC1 tail. Exogenous expression of the human PC1 tail results in renal cyst formation in zebrafish embryos. These results identify a novel mechanism of cilia function in the transduction of a mechanical signal to changes of gene expression involving PC1 and show that this pathway is inappropriately activated in ADPKD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16399078     DOI: 10.1016/j.devcel.2005.12.005

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   12.270


  152 in total

Review 1.  Polycystic liver diseases: congenital disorders of cholangiocyte signaling.

Authors:  Mario Strazzabosco; Stefan Somlo
Journal:  Gastroenterology       Date:  2011-04-22       Impact factor: 22.682

2.  Polycystin-1 regulates STAT activity by a dual mechanism.

Authors:  Jeffrey J Talbot; Jonathan M Shillingford; Shivakumar Vasanth; Nicholas Doerr; Sambuddho Mukherjee; Mike T Kinter; Terry Watnick; Thomas Weimbs
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-25       Impact factor: 11.205

Review 3.  Lessons from in vitro studies and a related intracellular angiotensin II transgenic mouse model.

Authors:  Julia L Cook; Richard N Re
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-12-14       Impact factor: 3.619

4.  Effect of PKD1 gene missense mutations on polycystin-1 membrane topogenesis.

Authors:  Nancy M Nims; Dianne Vassmer; Robin L Maser
Journal:  Biochemistry       Date:  2010-12-29       Impact factor: 3.162

Review 5.  How insights from cardiovascular developmental biology have impacted the care of infants and children with congenital heart disease.

Authors:  Alvin J Chin; Jean-Pierre Saint-Jeannet; Cecilia W Lo
Journal:  Mech Dev       Date:  2012-05-26       Impact factor: 1.882

6.  Polycystins and mechanotransduction: From physiology to disease.

Authors:  Christina Piperi; Efthimia K Basdra
Journal:  World J Exp Med       Date:  2015-11-20

Review 7.  Vasopressin and disruption of calcium signalling in polycystic kidney disease.

Authors:  Fouad T Chebib; Caroline R Sussman; Xiaofang Wang; Peter C Harris; Vicente E Torres
Journal:  Nat Rev Nephrol       Date:  2015-04-14       Impact factor: 28.314

Review 8.  A cut above (and below): Protein cleavage in the regulation of polycystin trafficking and signaling.

Authors:  Valeria Padovano; Kavita Mistry; David Merrick; Nikolay Gresko; Michael J Caplan
Journal:  Cell Signal       Date:  2020-04-10       Impact factor: 4.315

9.  Tudor-SN, a novel coactivator of peroxisome proliferator-activated receptor γ protein, is essential for adipogenesis.

Authors:  Zhongchao Duan; Xiujuan Zhao; Xiao Fu; Chao Su; Lingbiao Xin; Juha Saarikettu; Xi Yang; Zhi Yao; Olli Silvennoinen; Minxin Wei; Jie Yang
Journal:  J Biol Chem       Date:  2014-02-12       Impact factor: 5.157

Review 10.  MicroRNAs in the pathogenesis of cystic kidney disease.

Authors:  Yu Leng Phua; Jacqueline Ho
Journal:  Curr Opin Pediatr       Date:  2015-04       Impact factor: 2.856

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.